Selected article for: "case severity and chest radiographic"
Author: Huijie Bian; Zhao-Hui Zheng; Ding Wei; Zheng Zhang; Wen-Zhen Kang; Chun-Qiu Hao; Ke Dong; Wen Kang; Jie-Lai Xia; Jin-Lin Miao; Rong-Hua Xie; Bin Wang; Xiu-Xuan Sun; Xiang-Min Yang; Peng Lin; Jie-Jie Geng; Ke Wang; Hong-Yong Cui; Kui Zhang; Xiao-Chun Chen; Hao Tang; Hong Du; Na Yao; Shuang-Shuang Liu; Lin-Na Liu; Zhe Zhang; Zhao-Wei Gao; Gang Nan; Qing-Yi Wang; Jian-Qi Lian; Zhi-Nan Chen; Ping Zhu
Title: Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial
  • Document date: 2020_3_24
    • ID: 6g34qwer_2
    Snippet: Methods All patients received recommended strategy from Diagnosis and Treatment for 2019 Novel Coronavirus Diseases released by National Health Commission of China. Eligible patients were add-on administered 10 mg meplazumab intravenously at days 1, 2, and 5. Patients hospitalized in the same period were observed as concurrent control. The endpoints include virological clearance rate, case severity, chest radiographic, and laboratory test. This t.....
    Document: Methods All patients received recommended strategy from Diagnosis and Treatment for 2019 Novel Coronavirus Diseases released by National Health Commission of China. Eligible patients were add-on administered 10 mg meplazumab intravenously at days 1, 2, and 5. Patients hospitalized in the same period were observed as concurrent control. The endpoints include virological clearance rate, case severity, chest radiographic, and laboratory test. This trial was approved by the Ethics Committee of Institution at the Tangdu hospital, and registered with ClinicalTrials.gov, NCT 04275245.

    Search related documents:
    Co phrase search for related documents
    • case severity and concurrent control: 1, 2, 3, 4
    • case severity and laboratory test: 1, 2, 3
    • case severity and laboratory test chest radiographic case severity: 1
    • case severity and Tangdu hospital: 1, 2
    • clearance rate and concurrent control: 1
    • clearance rate and laboratory test: 1
    • clearance rate and laboratory test chest radiographic case severity: 1
    • clearance rate and Tangdu hospital: 1
    • concurrent control and laboratory test: 1, 2
    • concurrent control and laboratory test chest radiographic case severity: 1
    • concurrent control and Tangdu hospital: 1, 2
    • laboratory test and Tangdu hospital: 1
    • laboratory test chest radiographic case severity and Tangdu hospital: 1